首页 > 最新文献

Inmunologia (Barcelona, Spain : 1987)最新文献

英文 中文
La nueva revista online “Inmunología”: Ciencia para todos 新的在线杂志《免疫学》:面向所有人的科学
Pub Date : 2014-10-01 DOI: 10.1016/j.inmuno.2014.09.001
David Sancho
{"title":"La nueva revista online “Inmunología”: Ciencia para todos","authors":"David Sancho","doi":"10.1016/j.inmuno.2014.09.001","DOIUrl":"10.1016/j.inmuno.2014.09.001","url":null,"abstract":"","PeriodicalId":88896,"journal":{"name":"Inmunologia (Barcelona, Spain : 1987)","volume":"33 4","pages":"Pages 111-112"},"PeriodicalIF":0.0,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.inmuno.2014.09.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54645683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicción del número de linfocitos T CD4 en sangre periférica a partir de teoría de conjuntos y probabilidad en pacientes con VIH/SIDA 从集合理论和概率理论预测hiv / aids患者外周血中CD4 T淋巴细胞数量
Pub Date : 2014-10-01 DOI: 10.1016/j.inmuno.2014.07.001
Javier Rodríguez , Signed Prieto , Martha Melo , Darío Domínguez , Catalina Correa , Yolanda Soracipa , Marcela Mejía , Laura Valero , Alejandro Salamanca

Previously a refinement of a methodology was developed based on set theory and probability, with the aim of improving the predictive ability of CD4 T cells (LT-CD4) for HIV/AIDS from the total number of leukocytes and lymphocytes. In this work the clinical applicability of the method was shown by refining prediction in 150 samples. Taking data of leukocytes/mm3, lymphocytes/mm3, and LT-CD4 cells/mm3 of each patient, called triples, they were organized from highest to lowest based on the number of leukocytes, to evaluate ranges of 1,000 leukocytes. The membership of the triples to the set A∪C, B∪D was established, as well as the intersection between the two sets (A∪B)∩(B∪D), in which a prediction of the number of CD4 associated with specific values of leukocytes and lymphocytes is established. The number of elements belonging to each set was counted and the probability of belonging to each of the ranges tested was determined. A total of 7 out of the 9 ranges of leukocytes measured showed a probability of success equal to or greater than 0,76, achieving a probability of 1 in the ranks lower than 4.000/mm3 and 3.000/mm3, respectively. The ability of the methodology for determining the value of the LT-CD4 was demonstrated, achieving a higher predictive capacity than the unrefined methodology. The evidence shows that the applied methodology is effective for clinical use, thus leading to a reduction of costs and resources.

此前,一种基于集合理论和概率的方法得到了改进,目的是从白细胞和淋巴细胞的总数中提高CD4 T细胞(LT-CD4)对艾滋病毒/艾滋病的预测能力。在这项工作中,该方法的临床适用性通过对150个样本的细化预测得到了证明。取每个患者的白细胞/mm3、淋巴细胞/mm3和LT-CD4细胞/mm3的数据,称为三组,根据白细胞的数量从高到低进行组织,以评估1000个白细胞的范围。建立了这两个三元组对集合A∪C, B∪D的隶属关系,以及这两个集合(A∪B)∩(B∪D)之间的交集,从而建立了CD4的数量与白细胞和淋巴细胞的特定值相关的预测。计算属于每个集合的元素数量,并确定属于每个测试范围的概率。在所测量的9个白细胞范围中,共有7个显示成功概率等于或大于0.76,在低于4.000/mm3和3.000/mm3的级别中分别获得1的概率。证明了该方法确定LT-CD4值的能力,比未改进的方法具有更高的预测能力。证据表明,应用的方法是有效的临床应用,从而导致成本和资源的减少。
{"title":"Predicción del número de linfocitos T CD4 en sangre periférica a partir de teoría de conjuntos y probabilidad en pacientes con VIH/SIDA","authors":"Javier Rodríguez ,&nbsp;Signed Prieto ,&nbsp;Martha Melo ,&nbsp;Darío Domínguez ,&nbsp;Catalina Correa ,&nbsp;Yolanda Soracipa ,&nbsp;Marcela Mejía ,&nbsp;Laura Valero ,&nbsp;Alejandro Salamanca","doi":"10.1016/j.inmuno.2014.07.001","DOIUrl":"10.1016/j.inmuno.2014.07.001","url":null,"abstract":"<div><p>Previously a refinement of a methodology was developed based on set theory and probability, with the aim of improving the predictive ability of CD4 T cells (LT-CD4) for HIV/AIDS from the total number of leukocytes and lymphocytes. In this work the clinical applicability of the method was shown by refining prediction in 150 samples. Taking data of leukocytes/mm<sup>3</sup>, lymphocytes/mm<sup>3</sup>, and LT-CD4 cells/mm<sup>3</sup> of each patient, called triples, they were organized from highest to lowest based on the number of leukocytes, to evaluate ranges of 1,000 leukocytes. The membership of the triples to the set A∪C, B∪D was established, as well as the intersection between the two sets (A∪B)∩(B∪D), in which a prediction of the number of CD4 associated with specific values of leukocytes and lymphocytes is established. The number of elements belonging to each set was counted and the probability of belonging to each of the ranges tested was determined. A total of 7 out of the 9 ranges of leukocytes measured showed a probability of success equal to or greater than 0,76, achieving a probability of 1 in the ranks lower than 4.000/mm<sup>3</sup> and 3.000/mm<sup>3</sup>, respectively. The ability of the methodology for determining the value of the LT-CD4 was demonstrated, achieving a higher predictive capacity than the unrefined methodology. The evidence shows that the applied methodology is effective for clinical use, thus leading to a reduction of costs and resources.</p></div>","PeriodicalId":88896,"journal":{"name":"Inmunologia (Barcelona, Spain : 1987)","volume":"33 4","pages":"Pages 113-120"},"PeriodicalIF":0.0,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.inmuno.2014.07.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54645481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Aspectos inmunogenéticos de la psoriasis con énfasis en micro-ARN 银屑病的免疫遗传学方面,重点研究微rna
Pub Date : 2014-10-01 DOI: 10.1016/j.inmuno.2014.07.002
Verónica Ruiz Cañas , Margarita Velásquez Lopera , Luis F. Barrera Robledo

Psoriasis is a chronic inflammatory disease of the skin, of autoimmune origin, with different cells implicated in the aetiopathology, such as T helper lymphocytes (Th1 and Th17), keratinocytes, and cytokines produced by these cells. The epigenetic regulatory mechanisms are the junction between environmental exposure and genetic factors. It is known that microRNAs (miRNAs), single chain RNAs, are actively involved in epigenetic regulation. Alterations in the miR-125b, miR-424, miR- 21 and miR-203 expression, and others, have been involved in different aspects of the disease. Global studies of miRNA expression performed using microarrays and by direct RNA sequencing revealed important differences in miRNA expression in normal skin and psoriatic individuals. These miRNAs can be considered as potential therapeutic targets or biomarkers of disease.

银屑病是一种自身免疫性皮肤慢性炎症性疾病,不同的细胞参与病因病理学,如辅助性T淋巴细胞(Th1和Th17)、角化细胞和由这些细胞产生的细胞因子。表观遗传调控机制是环境暴露与遗传因素之间的结合点。众所周知,单链rna (microRNAs, miRNAs)积极参与表观遗传调控。miR-125b、miR-424、miR- 21和miR-203等表达的改变与疾病的不同方面有关。使用微阵列和直接RNA测序进行的miRNA表达的全球研究揭示了正常皮肤和银屑病个体miRNA表达的重要差异。这些mirna可以被认为是潜在的治疗靶点或疾病的生物标志物。
{"title":"Aspectos inmunogenéticos de la psoriasis con énfasis en micro-ARN","authors":"Verónica Ruiz Cañas ,&nbsp;Margarita Velásquez Lopera ,&nbsp;Luis F. Barrera Robledo","doi":"10.1016/j.inmuno.2014.07.002","DOIUrl":"10.1016/j.inmuno.2014.07.002","url":null,"abstract":"<div><p>Psoriasis is a chronic inflammatory disease of the skin, of autoimmune origin, with different cells implicated in the aetiopathology, such as T helper lymphocytes (Th1 and Th17), keratinocytes, and cytokines produced by these cells. The epigenetic regulatory mechanisms are the junction between environmental exposure and genetic factors. It is known that microRNAs (miRNAs), single chain RNAs, are actively involved in epigenetic regulation. Alterations in the miR-125b, miR-424, miR- 21 and miR-203 expression, and others, have been involved in different aspects of the disease. Global studies of miRNA expression performed using microarrays and by direct RNA sequencing revealed important differences in miRNA expression in normal skin and psoriatic individuals. These miRNAs can be considered as potential therapeutic targets or biomarkers of disease.</p></div>","PeriodicalId":88896,"journal":{"name":"Inmunologia (Barcelona, Spain : 1987)","volume":"33 4","pages":"Pages 137-146"},"PeriodicalIF":0.0,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.inmuno.2014.07.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54645574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identificación y utilidad clínica de los anticuerpos antineuronales 抗神经元抗体的鉴定及临床应用
Pub Date : 2014-10-01 DOI: 10.1016/j.inmuno.2014.04.003
Ángela Carrasco , Inmaculada Alarcón , Concepción González , Francesc Graus

We review the neuronal antibodies described in CNS disorders in order to clarify their diagnostic value. In this work, the neuronal antibodies associated with syndromes resulting from CNS neuronal dysfunction were classified into two groups according to the location of the antigen inside the neuron or in the cell membrane. Group I includes antibodies that target intracellular antigens and are probably not pathogenic. They include onconeural antibodies (Hu [ANNA1], Yo [PCA1], Ri [ANNA2], CV2 [CRMP5], amphiphysin, Ma2, Tr, SOX1), which are useful for the diagnosis of paraneoplastic neurological syndromes (PNS). Other antibodies of this group, mainly anti-glutamic acid decarboxylase (GAD) antibodies, identify non-paraneoplastic syndromes (PNS), such as stiff-person syndrome (SPS), cerebellar ataxia, and limbic encephalitis (LE). Group II antibodies recognize neuronal surface antigens. Antibodies in this group are associated with characteristic CNS syndromes, but their detection does not indicate that the disorder is paraneoplastic. The most frequent are the anti-receptor NMDA antibodies, followed by the antibodies against the protein LGI1 associated with the potassium channel. Other less common antibodies include those against the receptors of AMPA, GABAb, mGluR 1 and 5, and against CASPR2. A pathogenic role of the antibodies is suggested by the response of symptoms to immunotherapy, and the correlation between antibody titers and neurological outcome.

我们回顾了在中枢神经系统疾病中描述的神经元抗体,以阐明其诊断价值。在这项工作中,根据抗原在神经元内或细胞膜内的位置,将与中枢神经系统神经元功能障碍引起的综合征相关的神经元抗体分为两组。第一组包括针对细胞内抗原的抗体,可能不具有致病性。它们包括肿瘤神经抗体(Hu [ANNA1], Yo [PCA1], Ri [ANNA2], CV2 [CRMP5], amphiphysin, Ma2, Tr, SOX1),它们对副肿瘤神经综合征(PNS)的诊断有用。该组的其他抗体,主要是抗谷氨酸脱羧酶(GAD)抗体,用于识别非副肿瘤综合征(PNS),如僵硬人综合征(SPS)、小脑性共济失调和边缘脑炎(LE)。II组抗体识别神经元表面抗原。本组抗体与特征性中枢神经系统综合征相关,但其检测结果并不表明该疾病为副肿瘤。最常见的是抗受体NMDA抗体,其次是抗与钾通道相关的LGI1蛋白的抗体。其他不太常见的抗体包括针对AMPA、GABAb、mGluR 1和5受体的抗体,以及针对CASPR2的抗体。症状对免疫治疗的反应以及抗体滴度与神经预后之间的相关性表明抗体的致病作用。
{"title":"Identificación y utilidad clínica de los anticuerpos antineuronales","authors":"Ángela Carrasco ,&nbsp;Inmaculada Alarcón ,&nbsp;Concepción González ,&nbsp;Francesc Graus","doi":"10.1016/j.inmuno.2014.04.003","DOIUrl":"10.1016/j.inmuno.2014.04.003","url":null,"abstract":"<div><p>We review the neuronal antibodies described in CNS disorders in order to clarify their diagnostic value. In this work, the neuronal antibodies associated with syndromes resulting from CNS neuronal dysfunction were classified into two groups according to the location of the antigen inside the neuron or in the cell membrane. Group <span>I</span> includes antibodies that target intracellular antigens and are probably not pathogenic. They include onconeural antibodies (Hu [ANNA1], Yo [PCA1], Ri [ANNA2], CV2 [CRMP5], amphiphysin, Ma2, Tr, SOX1), which are useful for the diagnosis of paraneoplastic neurological syndromes (PNS). Other antibodies of this group, mainly anti-glutamic acid decarboxylase (GAD) antibodies, identify non-paraneoplastic syndromes (PNS), such as stiff-person syndrome (SPS), cerebellar ataxia, and limbic encephalitis (LE). Group <span>II</span> antibodies recognize neuronal surface antigens. Antibodies in this group are associated with characteristic CNS syndromes, but their detection does not indicate that the disorder is paraneoplastic. The most frequent are the anti-receptor NMDA antibodies, followed by the antibodies against the protein LGI1 associated with the potassium channel. Other less common antibodies include those against the receptors of AMPA, GABAb, mGluR 1 and 5, and against CASPR2. A pathogenic role of the antibodies is suggested by the response of symptoms to immunotherapy, and the correlation between antibody titers and neurological outcome.</p></div>","PeriodicalId":88896,"journal":{"name":"Inmunologia (Barcelona, Spain : 1987)","volume":"33 4","pages":"Pages 128-136"},"PeriodicalIF":0.0,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.inmuno.2014.04.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54644910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Tolerancia oral en artritis experimental inducida por antígeno en conejos por administración de hidrolizado de cartílago articular 关节软骨水解物对兔实验性抗原诱导关节炎的口服耐受性
Pub Date : 2014-10-01 DOI: 10.1016/j.inmuno.2014.06.003
David B. Abramson , Julieta Cabello , Gastón E. Bumaguin , Alexis Jamín , Ezequiel J. Vitelli , Natalí Zingoni , Leandro Sarrió , Sara Feldman , Gustavo R. Cointry

Rheumatoid arthritis is an autoimmune disease characterized by polyarticular inflammation, swelling and inflammation that affects more than 1% of the world population. The pathobiology of rheumatoid arthritis involves several cell populations as T lymphocytes, B, macrófagosy fibroblasts, and a complex proinflammatory cytokines interactions. Conventional and biologic therapies do not always work or produce only a partial improvement. Immunological tolerance is a mechanism by which the immune system prevents autoreactivity. The aim of this pilot study was to evaluate the efficacy of peptides from an from articular cartilage hydrolysate extracted of tarsus (HCA) for the treatment of rheumatoid arthritis in a model of rheumatoid arthritis (AAE) in rabbits. AAE animals showed inflammation and pain within de first month of the primary immunization that was reversed in the AAE + HCA group. The control group showed a normal unnaffected synovial tissue. The AAE group revealed an inflamatory process whith synovial hyperplasia, filtering in lymphocytes and vascular proliferation. The treated group decreased significantly inflammation, lymphocyte proliferation and angiogenesis. Arthritic rabbits increased the levels in flammatory markers as nitric oxide, interferon gamma (INF-ɣ) and tumor necrosis factor alpha (TNF-α) compared to control and significantly reduced levels of interleukin 4 (IL-4). The treatment showed a significant reduction of nitricoxide, IFN-gamma and TNF-alpha and an increase in IL-4. This work suggests that this therapy may be useful in the clinical aspect and the biochemical and immune parameters. Future studies with larger numbers of animals and other laboratory parameters may provide additional evidence in this regard.

类风湿性关节炎是一种以多关节炎症、肿胀和炎症为特征的自身免疫性疾病,影响着世界上1%以上的人口。类风湿关节炎的病理生物学涉及多个细胞群,如T淋巴细胞、B细胞、macrófagosy成纤维细胞和复杂的促炎细胞因子相互作用。传统疗法和生物疗法并不总是有效或只能产生部分改善。免疫耐受是免疫系统防止自身反应的一种机制。本初步研究的目的是评估从跗骨提取的关节软骨水解物(HCA)中提取的肽对兔类风湿关节炎(AAE)模型治疗类风湿关节炎的疗效。AAE动物在初次免疫后的第一个月内出现炎症和疼痛,而AAE + HCA组则相反。对照组滑膜组织正常,未受影响。AAE组表现为滑膜增生、淋巴细胞滤过、血管增生等炎症过程。治疗组炎症、淋巴细胞增殖和血管生成明显减少。与对照组相比,关节炎家兔炎症标志物如一氧化氮、干扰素γ (INF- α)和肿瘤坏死因子α (TNF-α)水平升高,白细胞介素4 (IL-4)水平显著降低。治疗显示一氧化氮、ifn - γ和tnf - α显著减少,IL-4显著增加。这项工作表明,该疗法可能在临床方面和生化和免疫参数方面有用。未来的大量动物实验和其他实验室参数的研究可能会在这方面提供更多的证据。
{"title":"Tolerancia oral en artritis experimental inducida por antígeno en conejos por administración de hidrolizado de cartílago articular","authors":"David B. Abramson ,&nbsp;Julieta Cabello ,&nbsp;Gastón E. Bumaguin ,&nbsp;Alexis Jamín ,&nbsp;Ezequiel J. Vitelli ,&nbsp;Natalí Zingoni ,&nbsp;Leandro Sarrió ,&nbsp;Sara Feldman ,&nbsp;Gustavo R. Cointry","doi":"10.1016/j.inmuno.2014.06.003","DOIUrl":"10.1016/j.inmuno.2014.06.003","url":null,"abstract":"<div><p>Rheumatoid arthritis is an autoimmune disease characterized by polyarticular inflammation, swelling and inflammation that affects more than 1% of the world population. The pathobiology of rheumatoid arthritis involves several cell populations as T lymphocytes, B, macrófagosy fibroblasts, and a complex proinflammatory cytokines interactions. Conventional and biologic therapies do not always work or produce only a partial improvement. Immunological tolerance is a mechanism by which the immune system prevents autoreactivity. The aim of this pilot study was to evaluate the efficacy of peptides from an from articular cartilage hydrolysate extracted of tarsus (HCA) for the treatment of rheumatoid arthritis in a model of rheumatoid arthritis (AAE) in rabbits. AAE animals showed inflammation and pain within de first month of the primary immunization that was reversed in the AAE + HCA group. The control group showed a normal unnaffected synovial tissue. The AAE group revealed an inflamatory process whith synovial hyperplasia, filtering in lymphocytes and vascular proliferation. The treated group decreased significantly inflammation, lymphocyte proliferation and angiogenesis. Arthritic rabbits increased the levels in flammatory markers as nitric oxide, interferon gamma (INF-ɣ) and tumor necrosis factor alpha (TNF-α) compared to control and significantly reduced levels of interleukin 4 (IL-4). The treatment showed a significant reduction of nitricoxide, IFN-gamma and TNF-alpha and an increase in IL-4. This work suggests that this therapy may be useful in the clinical aspect and the biochemical and immune parameters. Future studies with larger numbers of animals and other laboratory parameters may provide additional evidence in this regard.</p></div>","PeriodicalId":88896,"journal":{"name":"Inmunologia (Barcelona, Spain : 1987)","volume":"33 4","pages":"Pages 121-127"},"PeriodicalIF":0.0,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.inmuno.2014.06.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54645413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Fracaso de omalizumab en una urticaria solar grave inducida por ultravioleta 奥玛珠单抗在紫外线引起的严重太阳荨麻疹中的失败
Pub Date : 2014-10-01 DOI: 10.1016/j.inmuno.2014.08.001
Alejandra Pérez-Plaza, María José Concha-Garzón, Guillermo Solano-López, Diego de Argila
{"title":"Fracaso de omalizumab en una urticaria solar grave inducida por ultravioleta","authors":"Alejandra Pérez-Plaza,&nbsp;María José Concha-Garzón,&nbsp;Guillermo Solano-López,&nbsp;Diego de Argila","doi":"10.1016/j.inmuno.2014.08.001","DOIUrl":"10.1016/j.inmuno.2014.08.001","url":null,"abstract":"","PeriodicalId":88896,"journal":{"name":"Inmunologia (Barcelona, Spain : 1987)","volume":"33 4","pages":"Pages 147-148"},"PeriodicalIF":0.0,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.inmuno.2014.08.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54645658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
3.° Encuentro sobre Células Dendríticas y Macrófagos en Madrid 3.在马德里举行的树突状细胞和巨噬细胞会议
Pub Date : 2014-10-01 DOI: 10.1016/j.inmuno.2014.06.002
David Gamarra Carrasco
{"title":"3.° Encuentro sobre Células Dendríticas y Macrófagos en Madrid","authors":"David Gamarra Carrasco","doi":"10.1016/j.inmuno.2014.06.002","DOIUrl":"10.1016/j.inmuno.2014.06.002","url":null,"abstract":"","PeriodicalId":88896,"journal":{"name":"Inmunologia (Barcelona, Spain : 1987)","volume":"33 4","pages":"Pages 149-151"},"PeriodicalIF":0.0,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.inmuno.2014.06.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54645347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
El factor de crecimiento del hepatocito disminuye la expresión vascular de mediadores inflamatorios y la hipertensión en ratas espontáneamente hipertensas 肝细胞生长因子降低自发性高血压大鼠血管炎症介质表达和高血压
Pub Date : 2014-07-01 DOI: 10.1016/j.inmuno.2014.05.002
Maribel Chávez-Velásquez , Mariela Pérez , José L. Arcaya , Alberto J. García , Enrique Talavera , Freddy Romero-Vásquez

Objective

This study was designed to examine the effects of hepatocyte growth factor (HGF) gene delivery on vascular inflammation and hypertension in spontaneously hypertensive rats (SHR). We speculated that HGF deficiency could play a key role in the pathogenesis of hypertension in SHR, and that increasing HGF levels will produce prolonged decreases in blood pressure due to reduced vascular inflammation.

Materials and methods

Fifteen-week old male SHRs received weekly hydrodynamic injections of a naked plasmid containing human HGF (pCMV-HGF) (1 mg/kg) or empty vector (pcDNA3.1) for 6 weeks. Two groups of Wistar-Kyoto (WKY) rats were used as controls (n = 6) and treated in the same manner. The activation of NF-κB was assessed by Western blot and mRNA expression of pro-inflammatory cytokines by real-time PCR and Western blot.

Results

Blood pressure, NF-κB activation and expression of IL-6, MCP-1 and RANTES were significantly higher in SHR than in the control WKY. The HGF gene therapy normalized NF-κB activity, pro-inflammatory cytokines expression, and decreased the hypertension in SHR.

Conclusion

These observations suggest that decreased aorta HGF concentration may have a role in the vascular inflammation observed in SHR, and demonstrate that increasing HGF is a potential therapeutic target in the treatment of hypertension.

目的探讨肝细胞生长因子(HGF)基因传递对自发性高血压大鼠血管炎症和高血压的影响。我们推测HGF缺乏可能在SHR高血压发病机制中发挥关键作用,HGF水平升高会导致血管炎症减少,导致血压持续下降。材料与方法15周龄雄性SHRs每周接受含人HGF裸质粒(pCMV-HGF) (1 mg/kg)或空载体(pcDNA3.1)的流体动力学注射,持续6周。以两组Wistar-Kyoto (WKY)大鼠为对照(n = 6),采用相同方法处理。Western blot检测NF-κB的活化,real-time PCR和Western blot检测促炎细胞因子mRNA的表达。结果SHR组血压、NF-κB活化及IL-6、MCP-1、RANTES表达明显高于对照组。HGF基因治疗可使SHR患者的NF-κB活性和促炎细胞因子表达正常,降低高血压。结论主动脉HGF浓度降低可能与SHR的血管炎症有关,提示HGF升高可能是高血压治疗的潜在靶点。
{"title":"El factor de crecimiento del hepatocito disminuye la expresión vascular de mediadores inflamatorios y la hipertensión en ratas espontáneamente hipertensas","authors":"Maribel Chávez-Velásquez ,&nbsp;Mariela Pérez ,&nbsp;José L. Arcaya ,&nbsp;Alberto J. García ,&nbsp;Enrique Talavera ,&nbsp;Freddy Romero-Vásquez","doi":"10.1016/j.inmuno.2014.05.002","DOIUrl":"10.1016/j.inmuno.2014.05.002","url":null,"abstract":"<div><h3>Objective</h3><p>This study was designed to examine the effects of hepatocyte growth factor (HGF) gene delivery on vascular inflammation and hypertension in spontaneously hypertensive rats (SHR). We speculated that HGF deficiency could play a key role in the pathogenesis of hypertension in SHR, and that increasing HGF levels will produce prolonged decreases in blood pressure due to reduced vascular inflammation.</p></div><div><h3>Materials and methods</h3><p>Fifteen-week old male SHRs received weekly hydrodynamic injections of a naked plasmid containing human HGF (pCMV-HGF) (1<!--> <!-->mg/kg) or empty vector (pcDNA3.1) for 6 weeks. Two groups of Wistar-Kyoto (WKY) rats were used as controls (n<!--> <!-->=<!--> <!-->6) and treated in the same manner. The activation of NF-κB was assessed by Western blot and mRNA expression of pro-inflammatory cytokines by real-time PCR and Western blot.</p></div><div><h3>Results</h3><p>Blood pressure, NF-κB activation and expression of IL-6, MCP-1 and RANTES were significantly higher in SHR than in the control WKY. The HGF gene therapy normalized NF-κB activity, pro-inflammatory cytokines expression, and decreased the hypertension in SHR.</p></div><div><h3>Conclusion</h3><p>These observations suggest that decreased aorta HGF concentration may have a role in the vascular inflammation observed in SHR, and demonstrate that increasing HGF is a potential therapeutic target in the treatment of hypertension.</p></div>","PeriodicalId":88896,"journal":{"name":"Inmunologia (Barcelona, Spain : 1987)","volume":"33 3","pages":"Pages 87-95"},"PeriodicalIF":0.0,"publicationDate":"2014-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.inmuno.2014.05.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54645173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HLA-DPA1*/DPB1* en asociación con leucemias linfoides agudas y leucemias mieloides crónicas en mestizos venezolanos HLA-DPA1*/DPB1*与委内瑞拉混血儿急性淋巴细胞白血病和慢性髓系白血病相关
Pub Date : 2014-07-01 DOI: 10.1016/j.inmuno.2014.04.001
Sergio Rivera Pirela , Miriam Echeverría , Georgina Márquez , Zuhey Carrillo , Yennis Parra , Pedro Salcedo , Melchor Álvarez de Mon Soto

More is now known of the involvement of HLA-DP region in the pathogenesis of the leukemias through several previousstudies showing interference of these molecules in modulating the immune response to pathogens. For evaluation of HLA alleles and haplotypes DPA1*/DPB1* (28 alleles HLA DPA1* and 123 of HLA- DPB1*) Olerup SSP ™PCR (Genovision) was used in 48 patients with ALL, 48 CML, and 48 Venezuelan twins as controls. For HLA/leukemias, a relative risk (RR) > 3 was considered to be a positive association and negative with an RR < 3, with a p corrected P<.05. ALL patients confirmed positive associations with DPA1*0105 allele, and negative with DPA1*010301-010302. In addition, they were positively associated with DPA1*0106 and *0107, with DPA1*020101-020106 being negatively associated with ALL. DPA1*0105, *0108 and *0109 were negatively associated with CML. The observed frequencies of HLA-DPB1* 01:01, 02:01, 03:01, 04:01 and 4:02 alleles in Venezuelan, which twins were between 7 and 16%, were higher than those of leukemic patients. Negative associations of DPB1*2:01, *3:01 and LLA were confined. No positive associations were observed with ALL. Non-confirmed positive associations were observed between DPB1*99:01 and CML. Haplotypes HLA-DPA1*01:03-DPB1*4:01, *2:01, *99:01 were strongly positively associated with CML. DPA1*1:09-DPB1*2:01, *4:01 were negatively associated with the CML. DPA1*1:03-DPB1*4:02; DPA1*01:09-DPB1*2:01, *4:01 and DPA1*02:01-DPB1*04:02 were negatively associated with ALL. The DPB1* single region does not appear to be associated with leukemia in the Venezuelan population. The strong association with several haplotypes DPA*1/DPB1* and LMC suggests massive differences between the pathogenesis of both diseases.

通过先前的几项研究显示HLA-DP分子在调节对病原体的免疫反应中的干扰,现在对HLA-DP区域参与白血病发病机制的了解更多。为了评估HLA等位基因和单倍型DPA1*/DPB1*(28个HLA DPA1*等位基因和123个HLA- DPB1*等位基因),采用Olerup SSP™PCR (Genovision)对48例ALL患者,48例CML患者和48例委内瑞拉双胞胎进行对照。HLA/白血病的相对危险度(RR) >3被认为是正相关,负相关与RR <3, p校正P< 0.05。所有患者均与DPA1*0105等位基因呈阳性,与DPA1*010301-010302呈阴性。与DPA1*0106、*0107呈正相关,DPA1*020101-020106与ALL呈负相关。DPA1*0105、*0108、*0109与CML呈负相关。委内瑞拉双胞胎HLA-DPB1* 01:01、02:01、03:01、04:01和4:02等位基因的频率在7% ~ 16%之间,高于白血病患者。DPB1*2:01、*3:01与LLA呈负相关。与ALL无正相关。DPB1*99:01与CML存在未证实的正相关。单倍型HLA-DPA1*01:03-DPB1*4:01, *2:01, *99:01与CML呈显著正相关。DPA1*1:09-DPB1*2:01、*4:01与CML呈负相关。DPA1 * 1:03-DPB1 * 4:02;DPA1*01:09-DPB1*2:01、DPA1* 4:01、DPA1*02:01-DPB1*04:02与ALL呈负相关。在委内瑞拉人群中,DPB1*单一区域似乎与白血病无关。与几个单倍型DPA*1/DPB1*和LMC的强关联表明这两种疾病的发病机制存在巨大差异。
{"title":"HLA-DPA1*/DPB1* en asociación con leucemias linfoides agudas y leucemias mieloides crónicas en mestizos venezolanos","authors":"Sergio Rivera Pirela ,&nbsp;Miriam Echeverría ,&nbsp;Georgina Márquez ,&nbsp;Zuhey Carrillo ,&nbsp;Yennis Parra ,&nbsp;Pedro Salcedo ,&nbsp;Melchor Álvarez de Mon Soto","doi":"10.1016/j.inmuno.2014.04.001","DOIUrl":"10.1016/j.inmuno.2014.04.001","url":null,"abstract":"<div><p>More is now known of the involvement of HLA-DP region in the pathogenesis of the leukemias through several previousstudies showing interference of these molecules in modulating the immune response to pathogens. For evaluation of HLA alleles and haplotypes DPA1*/DPB1* (28 alleles HLA DPA1* and 123 of HLA- DPB1*) Olerup SSP ™PCR (Genovision) was used in 48 patients with ALL, 48 CML, and 48 Venezuelan twins as controls. For HLA/leukemias, a relative risk (RR) &gt; 3 was considered to be a positive association and negative with an RR<!--> <!-->&lt;<!--> <!-->3, with a p corrected <em>P</em>&lt;.05. ALL patients confirmed positive associations with DPA1*0105 allele, and negative with DPA1*010301-010302. In addition, they were positively associated with DPA1*0106 and *0107, with DPA1*020101-020106 being negatively associated with ALL. DPA1*0105, *0108 and *0109 were negatively associated with CML. The observed frequencies of HLA-DPB1* 01:01, 02:01, 03:01, 04:01 and 4:02 alleles in Venezuelan, which twins were between 7 and 16%, were higher than those of leukemic patients. Negative associations of DPB1*2:01, *3:01 and LLA were confined. No positive associations were observed with ALL. Non-confirmed positive associations were observed between DPB1*99:01 and CML. Haplotypes HLA-DPA1*01:03-DPB1*4:01, *2:01, *99:01 were strongly positively associated with CML. DPA1*1:09-DPB1*2:01, *4:01 were negatively associated with the CML. DPA1*1:03-DPB1*4:02; DPA1*01:09-DPB1*2:01, *4:01 and DPA1*02:01-DPB1*04:02 were negatively associated with ALL. The DPB1* single region does not appear to be associated with leukemia in the Venezuelan population. The strong association with several haplotypes DPA*1/DPB1* and LMC suggests massive differences between the pathogenesis of both diseases.</p></div>","PeriodicalId":88896,"journal":{"name":"Inmunologia (Barcelona, Spain : 1987)","volume":"33 3","pages":"Pages 81-86"},"PeriodicalIF":0.0,"publicationDate":"2014-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.inmuno.2014.04.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54644617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validación de la técnica de dihidrorodamina 123 para el diagnóstico de la enfermedad granulomatosa crónica en Colombia 二氢罗胺123技术在哥伦比亚慢性肉芽肿性疾病诊断中的验证
Pub Date : 2014-07-01 DOI: 10.1016/j.inmuno.2014.03.001
Jessica Lineth Rojas-Restrepo, Jesús Armando Álvarez-Álvarez, Juan David Montoya-Giraldo, Claudia Milena Trujillo-Vargas

Introduction

Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by defects in the respiratory burst of phagocytes. Affected patients often suffer from granulomas and recurrent infections, mainly due to encapsulated bacteria.

Aim

To standardize the dihydrorhodamine test (DHR) in Colombia used for the diagnosis of CGD by evaluating the respiratory burst in human blood neutrophils and monocytes after in vitro activation.

Methods

Phagocyte respiratory burst in peripheral blood samples from 10 healthy controls was evaluated by flow cytometry after leukocyte activation with several concentrations of phorbol myristate acetate (PMA). The different oxidation patterns of DHR in X-linked or autosomal recessive CGD were also obtained.

Results

The most suitable concentrations of PMA for the evaluation of the respiratory burst in peripheral blood were 0.2 to 5 μg/ml. Reference values for this test in neutrophils from our population were established. It was shown that the oxidation patterns of DHR in monocytes were not always identical to those observed in neutrophils.

Conclusion

The evaluation of DHR oxidation by flow cytometry is a screening method that easily identifies the different phenotypes of CGD, with good sensitivity and at a lower cost. However, it is crucial that every laboratory establishes its own normal range for this test, in order to achieve the accurate characterization of this condition. DHR oxidation patterns may be also evaluated in different blood cells, since cell type-specific defects have also been reported.

慢性肉芽肿病(CGD)是一种由吞噬细胞呼吸爆发缺陷引起的原发性免疫缺陷。受影响的患者经常出现肉芽肿和反复感染,主要是由于被包裹的细菌。目的通过评价体外活化后人血液中性粒细胞和单核细胞的呼吸爆发,规范哥伦比亚二氢膦胺试验(DHR)诊断CGD的应用。方法采用流式细胞术观察10例健康人外周血白细胞经不同浓度肉豆酸酯佛醇(PMA)活化后的吞噬细胞呼吸爆发情况。在x连锁或常染色体隐性CGD中,DHR的氧化模式也不同。结果外周血PMA浓度为0.2 ~ 5 μg/ml是评价呼吸爆发的最适宜浓度。在我们的人群中建立了中性粒细胞的参考值。结果表明,单核细胞中DHR的氧化模式并不总是与中性粒细胞中观察到的相同。结论流式细胞术评价DHR氧化是一种易于识别不同表型CGD的筛选方法,具有良好的灵敏度和较低的成本。然而,至关重要的是,每个实验室都要为该测试建立自己的正常范围,以便准确表征这种情况。DHR氧化模式也可以在不同的血细胞中进行评估,因为细胞类型特异性缺陷也有报道。
{"title":"Validación de la técnica de dihidrorodamina 123 para el diagnóstico de la enfermedad granulomatosa crónica en Colombia","authors":"Jessica Lineth Rojas-Restrepo,&nbsp;Jesús Armando Álvarez-Álvarez,&nbsp;Juan David Montoya-Giraldo,&nbsp;Claudia Milena Trujillo-Vargas","doi":"10.1016/j.inmuno.2014.03.001","DOIUrl":"10.1016/j.inmuno.2014.03.001","url":null,"abstract":"<div><h3>Introduction</h3><p>Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by defects in the respiratory burst of phagocytes. Affected patients often suffer from granulomas and recurrent infections, mainly due to encapsulated bacteria.</p></div><div><h3>Aim</h3><p>To standardize the dihydrorhodamine test (DHR) in Colombia used for the diagnosis of CGD by evaluating the respiratory burst in human blood neutrophils and monocytes after in vitro activation.</p></div><div><h3>Methods</h3><p>Phagocyte respiratory burst in peripheral blood samples from 10 healthy controls was evaluated by flow cytometry after leukocyte activation with several concentrations of phorbol myristate acetate (PMA). The different oxidation patterns of DHR in X-linked or autosomal recessive CGD were also obtained.</p></div><div><h3>Results</h3><p>The most suitable concentrations of PMA for the evaluation of the respiratory burst in peripheral blood were 0.2 to 5<!--> <!-->μg/ml. Reference values for this test in neutrophils from our population were established. It was shown that the oxidation patterns of DHR in monocytes were not always identical to those observed in neutrophils.</p></div><div><h3>Conclusion</h3><p>The evaluation of DHR oxidation by flow cytometry is a screening method that easily identifies the different phenotypes of CGD, with good sensitivity and at a lower cost. However, it is crucial that every laboratory establishes its own normal range for this test, in order to achieve the accurate characterization of this condition. DHR oxidation patterns may be also evaluated in different blood cells, since cell type-specific defects have also been reported.</p></div>","PeriodicalId":88896,"journal":{"name":"Inmunologia (Barcelona, Spain : 1987)","volume":"33 3","pages":"Pages 71-80"},"PeriodicalIF":0.0,"publicationDate":"2014-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.inmuno.2014.03.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54644497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Inmunologia (Barcelona, Spain : 1987)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1